Skip to main content
Pfizer Inc.
Healthcare · Drug Manufacturers - General
Made on Jun 30, 2026
Price at call $24.39
6-month call Bull +6.6%
Target by Dec 2026 $25.99
Great value below $21.50
Model v0.3.0

Projection vs Actual (6M history + forecast)

Our straight 6-month prediction (bold) with a textured realism line, and the actual price overlaid from the prediction date forward.

Forecast

One directional 6-month call and the six monthly points we'll be scored against. Predicted Jun 30, 2026 3:13 am
Bull PFE trends higher to $25.99 (+6.6% from $24.39) by Dec 2026.
Monthmonths after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $24.39 at call
Prediction made Jun 30, 2026 $24.39 at call
M1 Jul 30, 2026 $24.65 +1.1%
What actually happened: closed $25.15 on Jul 29, 2026 = +3.1% vs the call (predicted +1.1%)  ·  direction HIT (called flat, was flat)  ·  off by 2.1 pp  ·  accuracy 9/10  ·  S&P -2.4% over the same window — beat it
M2 Aug 30, 2026 $24.92 +2.2%
M3 Sep 30, 2026 $25.19 +3.3%
M4 Oct 30, 2026 $25.46 +4.4%
M5 Nov 30, 2026 $25.72 +5.5%
M6 Dec 30, 2026 $25.99 +6.6%

Deserved value (DCF/composite) is $29.09; over 6 months we project closing only part-way to it (reach 34.2%). Value-only — see Not Yet Modeled below.

Weaknesses

0 blocking · 1 degraded · 1 note — follow the chain top-down (cause → effect).
  • Degraded
    High debt risk — interest coverage dangerously low or refinancing needed
    upstream:valuation-synthesis
  • Note
    Valuation anchor absent: dcf.
    anchor:dcf

Equation Inputs

Everything feeding the v0.3.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$24.39
Composite fair value$28.97
Signal-adjusted fair value$28.59
DCF fair value
Anchored-PE fair value$20.72
Buy-below (value lens)$21.50
Value net score+10
Value confidence6 / 10
Quality net score+2
Memo confidence6 / 10
Deserved value (base)$28.97
Quality tilt+0.4%
Deserved value (used)$29.09
Coherence (value × quality)1.00

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 22.6%  3m 20.5%  6m 21.3%  
Daily σ (realism noise)1.3%
Beta vs S&P 500 1m -0.02  3m 0.21  5m 0.24  
Trailing 6-month return-2.6%

Knobs (equation params)

Deserved wt · DCF0.5
Quality tilt cap (±)0.2
Horizon reach (6mo)0.45
Coherence floor (conflict)0.5
Conviction gain / pt0.06
Realism mean-reversion φ0.85
Conviction floor0.4
Deserved wt · composite0.5
Realism vol window3m
Neutral band (%)5
Horizon (months)6
Realism σ fallback0.015

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.3.0 #6bd904191719

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jun 30, 2026 freshest PFE-20260630-030500-2bec
ext-forensic-memo Jun 30, 2026 freshest ext-PFE-20260630-031147-c51d
ext-lens-quality Jun 30, 2026 freshest ext-PFE-20260630-031147-c51d
ext-lens-value Jun 30, 2026 freshest ext-PFE-20260630-031147-c51d
scenario-valuation Jun 30, 2026 freshest PFE-20260630-030500-2bec
valuation-synthesis Jun 30, 2026 freshest PFE-20260630-030500-2bec

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 6, 2026 v0.6.0 Bull $25.81 $27.75 +7.5% Feb 2027 view
Jun 30, 2026 v0.3.0 Bull $24.39 $25.99 +6.6% Dec 2026 viewing

Not Yet Modeled

What this v0.3.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Signal-adjusted fair value ($28.59) — the red-flag-adjusted anchor isn't the primary input yet (we use the raw DCF/composite blend, which double-counts DCF).
  • Recent momentum / drift — the line takes off straight; the trailing 6-month move (-2.6%) doesn't bend the slope.
  • Market beta — computed (1–5mo) for context but does not condition the path.
  • Earnings dates, catalysts, and known events — not modeled.
  • Macro regime & sector rotation — not modeled.
  • Horizon is a fixed 6-month assumption, not a modeled time-to-target.
  • Outcome scoring — predictions aren't yet graded against realized price once the evaluation date passes.